Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Some may think I'm crazy for buying more and more, in the last couple of weeks, $5.57, $5.33, $5.07, $4.40.

BUT, I look at it like this:
I go to a new car dealership and the car I love is $65,000, and I say I'll decide in a couple of weeks.
OK, I go back two weeks later and the exact same car is priced at $55,000.
If I loved it at 65K, how MUCH MORE do I love it at 55K.
Nothing changed, it's the same car as it was two weeks ago.

What has changed with MRKR in 2019?
WE got Positive news on pancreatic cancer (that's good).
We still had NOT A SINGLE case of cytokine release syndrome (that's good).
We still have epitope spreading with MultiTAA (that's good).
From a company point of view, it's a better company than it was on January 1st 2019.

The only negatives are, in January we had 1 million shares shorted, now we have 5 million (not the companies fault).
The share price bombed (not the companies fault).

It will revert back given time, the shorts will have to buy to cover and we will all (investors and patients) be rewarded for our faith.